Overview

Nebulized Heparin for the Treatment of COVID-19

Status:
Completed

Trial end date:
2021-08-23

Target enrollment:

Participant gender:

Summary

Randomized, placebo controlled study to determine if nebulized heparin may reduce the need for mechanical ventilation in hospitalized patients with the novel coronavirus, also known as COVID-19. This will be a part of a larger meta-trial.

Phase:

Phase 4

Details

Lead Sponsor:

Frederick Health

Treatments:

Heparin